New hope for leukemia patients after other treatments fail
NCT ID NCT07039877
Summary
This study is testing a combination of several drugs to try to get relapsed or treatment-resistant acute lymphoblastic leukemia (ALL) back under control. The goal is to achieve a strong response so patients can then receive a potentially curative stem cell transplant. It is for adults with B-cell or T-cell ALL that has returned or not responded to prior therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBKASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Dr. Jose E. Gonzalez
RECRUITINGMonterrey, Nuevo León, 64360, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.